title: Adhesion prevention in endometriosis: a neglected critical challenge.
abstract: Prevention of adhesions, whether de novo or by re-formation, is one of the most important and surprisingly neglected aspect of the treatment of endometriosis. Adhesions may cause infertility, dyspareunia, chronic pelvic pain but also intestinal obstruction and complications at subsequent surgery. They may play a role in the development of some forms of the disease such as ovarian endometriomas and possibly also deep invasive nodules. Three randomized controlled trials have been published documenting some partial success with Interceed, Oxiplex/AP gel or Adept solution in reducing adhesions extent at second look laparoscopy performed a few weeks after initial surgery. However, data on relevant long-term outcomes such as fertility, pelvic pain or disease recurrences or other adhesions-related complications is lacking. Noteworthy, endometriosis is a chronic inflammatory disorder and the insult causing adhesions is expected to persist after surgery. Therefore preventing adhesion formation with exclusively agents at the time of surgery may be insufficient. Future studies should focus on a 2-step strategy that includes measures applied at the time of surgery and subsequent administration of agents able to prevent the development of new adhesions.
authors.affiliation: Fondazione Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy. dadosomigliana@yahoo.it
authors.forename: Edgardo
authors.initials: E
authors.lastname: Somigliana
authors.forename: Paola
authors.initials: P
authors.lastname: Vigano
authors.forename: Laura
authors.initials: L
authors.lastname: Benaglia
authors.forename: Andrea
authors.initials: A
authors.lastname: Busnelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Vercellini
authors.forename: Luigi
authors.initials: L
authors.lastname: Fedele
mesh_terms: D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D002483:Cellulose, Oxidized / Q000627:therapeutic use; D015314:Dialysis Solutions / Q000627:therapeutic use; D004715:Endometriosis / Q000150:complications*; D005260:Female; D005936:Glucans / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D000077607:Icodextrin; D011092:Polyethylene Glycols / Q000627:therapeutic use; D055502:Secondary Prevention; D000267:Tissue Adhesions / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery
chemical_list: D002483:Cellulose, Oxidized; D015314:Dialysis Solutions; D005936:Glucans; C060002:INTERCEED; C406630:Oxiplex; D000077607:Icodextrin; D011092:Polyethylene Glycols; D002482:Cellulose; D005947:Glucose